Cumberland Pharmaceuticals Announces New Kristalose(R) Agreement

NASHVILLE, Tenn., Sept. 11 /PRNewswire/ -- Cumberland Pharmaceuticals announced today it has signed an agreement with Inalco S.p.A. of Italy and its U.S. distributor, Inalco Pharmaceuticals, to assume full commercial responsibility for Kristalose® on an exclusive basis in the United States.

Back to news